Cytosorbents (CTSO) EBT Margin Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) EBT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 1,391.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -176.00 |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 2,114.00 |
| 10 | Cytosorbents | 23.46 Mn | 18.66 Mn | 6.13 Mn | -4,706.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,706.00 |
| Dec 31, 2025 | -3,974.00 |
| Sep 30, 2025 | 11,277.00 |
| Jun 30, 2025 | -13,411.00 |
| Mar 31, 2025 | 8,622.00 |
| Dec 31, 2024 | 12,008.00 |
| Sep 30, 2024 | 3,350.00 |
| Jun 30, 2024 | -967.00 |
| Mar 31, 2024 | -2,841.00 |
| Dec 31, 2023 | -6,507.00 |
| Sep 30, 2023 | -9,632.00 |
| Jun 30, 2023 | -4,080.00 |
| Mar 31, 2023 | -3,784.00 |
| Dec 31, 2022 | 4,806.00 |
| Sep 30, 2022 | -3,745.00 |
| Jun 30, 2022 | -7,114.00 |
| Mar 31, 2022 | -909.00 |
| Dec 31, 2021 | 590.00 |
| Sep 30, 2021 | -1,331.00 |
| Jun 30, 2021 | 6,224.00 |